发明名称 |
USE OF ESTRIOL FOR TREATING CLIMACTERIC OSTEOPOROSIS |
摘要 |
The invention relates to the use of estriol as the sole active ingredient for the production of a transdermal medicament which continuously releases the active ingredient for the treatment of climacteric osteoporosis. It has been shown according to the invention that estriol, which has up until now been thought ineffective for the treatment of climacteric osteoporosis, develops strong anti-osteoporotic effectiveness upon continuous transdermal application.
|
申请公布号 |
CA2131822(C) |
申请公布日期 |
2002.12.17 |
申请号 |
CA19932131822 |
申请日期 |
1993.03.18 |
申请人 |
|
发明人 |
ELGER, WALTER;SCHNEIDER, BIRGITT;HUBLER, DORIS;DITTGEN, MICHAEL;OETTEL, MICHAEL;ERNST, MICHAEL |
分类号 |
A61K9/06;A61K9/70;A61K31/565;A61P3/02;A61P19/10;A61P43/00;(IPC1-7):A61K31/565 |
主分类号 |
A61K9/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|